Department of Human Sciences, College of Education and Human Ecology, The Ohio State University, 1787 Neil Ave, Columbus, OH, 43210, USA.
Center for Innovation in Pediatric Practice, The Abigail Wexner Research Institute At Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA.
Addict Sci Clin Pract. 2021 May 12;16(1):30. doi: 10.1186/s13722-021-00237-7.
Homeless youth experience high rates of substance use disorders, exposures to violence, mental and physical health conditions, and mortality. They have been particularly affected by the opioid crisis. However, no study to date has used a randomized controlled design to test preventive interventions of opioid and other drug use among this vulnerable population. Resolution of youth homelessness through housing and supportive services including prevention services, often referred to as "Housing First," has great potential to reduce the likelihood for the development of an opioid use disorder as well as other problem behaviors associated with living on the streets. Housing First has been tested through randomized trials among homeless adults with mental health and substance use disorders, but has not been empirically tested for opioid prevention among homeless youth.
Homeless youth will be recruited from a drop-in shelter site frequented by disconnected youth; they will be screened for eligibility, including current homelessness, age 18-24 years, and not currently meeting criteria for opioid use disorder (OUD). In a controlled trial, 240 youth will then be randomized to one of two conditions, (1) housing + opioid and related risk prevention services, or (2) opioid and related risk prevention services alone. This project utilizes existing efficacious models of prevention to address opioid-related risks, including motivational interviewing, strengths-based outreach and advocacy, and an HIV risk preventive intervention. Follow-up will be conducted at 3, 6, 9 and 12-months post-baseline. The economic cost of each intervention will be determined to support implementation decisions with other providers and their funders.
This study will provide essential information for researchers and providers on the efficacy of housing + opioid and related risk prevention services in an RCT for effects on opioid use and mechanisms underlying change. Because youth experiencing homelessness are at increased risk for a variety of adverse outcomes, the proposed intervention may produce substantial health care benefits to the youths and society at large. Trial registration ClinicalTrials.gov, NCT04135703, Registered October 13, 2019, https://clinicaltrials.gov/ct2/show/NCT04135703?term=NCT04135703&draw=2&rank=1#contacts.
无家可归的青年经历着高比率的物质使用障碍、暴力暴露、精神和身体健康状况以及死亡率。他们受到阿片类药物危机的特别影响。然而,迄今为止,没有研究使用随机对照设计来测试针对这一脆弱人群的阿片类药物和其他药物使用的预防干预措施。通过住房和支持服务(包括预防服务)解决青年无家可归问题,通常被称为“先住后付”,这极大地降低了发展阿片类药物使用障碍以及与流落街头相关的其他问题行为的可能性。“先住后付”已通过针对有心理健康和物质使用障碍的无家可归成年人的随机试验进行了测试,但尚未在无家可归青年中针对阿片类药物预防进行实证测试。
将从一个经常有与社会脱节的青年光顾的收容所招募无家可归的青年;他们将接受资格筛选,包括当前无家可归、年龄在 18-24 岁之间、目前不符合阿片类药物使用障碍(OUD)标准。在一项对照试验中,240 名青年将被随机分配到两种条件之一,(1)住房+阿片类药物和相关风险预防服务,或(2)阿片类药物和相关风险预防服务。该项目利用现有的预防效果模型来解决与阿片类药物相关的风险,包括动机性访谈、基于优势的外展和宣传以及 HIV 风险预防干预。将在基线后 3、6、9 和 12 个月进行随访。将确定每种干预措施的经济成本,以支持与其他提供者及其资助者的实施决策。
本研究将为研究人员和提供者提供有关住房+阿片类药物和相关风险预防服务在 RCT 中对阿片类药物使用和变化机制的疗效的重要信息。由于无家可归的青年面临各种不良后果的风险增加,因此拟议的干预措施可能会给青年和整个社会带来巨大的医疗保健效益。试验注册ClinicalTrials.gov,NCT04135703,注册于 2019 年 10 月 13 日,https://clinicaltrials.gov/ct2/show/NCT04135703?term=NCT04135703&draw=2&rank=1#contacts。